Human immunodeficiency virus (HIV) RNA in plasma as the preferred target for therapy in patients with HIV infection: A critique

Clinical Infectious Diseases

Volumn 24, Issue 2, 1997, Pages 116-122

  Fessel, W Jeffrey ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RNA ANALYSIS;

EID: 0031052933     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.2.116     Document Type: Note

References (7)

1. De Gruttola V, Wulfsohn M, Fischl MA, Tsiatis A. Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex. J Acquire Immune Defic Syndr 1993; 6:359-65.
2. Choi S, Lagakos SW, Schooley RT, Volberding PA. CD4 + lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med 1993; 118:674-80.
3. Cohen J. Keystone's blunt message: "It's the virus, stupid." Science 1993; 260:292-3.
4. Levy, JA. Surrogate markers in AIDS research: Is there truth in numbers? JAMA 1996;276:161-2.
5. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society - USA. JAMA 1996; 276:146-54.
6. Havlir DV, Richman DD. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Ann Intern Med 1996; 124: 984-94.
7. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.